Medifast MED Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $76.04M+1.3% | $75.1M-16.0% | $89.41M-15.3% | $105.56M-8.8% | $115.73M-2.8% | ||
| $24.29M+5.8% | $22.96M-15.8% | $27.25M-5.7% | $28.91M-8.2% | $31.48M+2.3% | ||
| $51.76M-0.7% | $52.14M-16.1% | $62.16M-18.9% | $76.64M-9.0% | $84.25M-4.5% | ||
| 68.1%-1.4pp | 69.4%-0.1pp | 69.5%-3.1pp | 72.6%-0.2pp | 72.8%-1.3pp | ||
| $55.05M-8.2% | $59.94M-9.5% | $66.24M-14.8% | $77.71M-9.1% | $85.51M-2.3% | ||
| $3.48M+0.5% | $3.47M+0.4% | $3.45M-14.7% | $4.05M+23.3% | $3.28M+3.0% | ||
| -$3.3M+57.8% | -$7.8M-91.2% | -$4.08M-283% | -$1.07M+15.5% | -$1.26M-278% | ||
| -4.3%+6.1pp | -10.4%-5.8pp | -4.6%-3.6pp | -1%+0.1pp | -1.1%-1.7pp | ||
| $1.38M— | —— | $1.43M+4.2% | $1.37M+5.2% | $1.3M— | ||
| $1.35M-4.7% | $1.42M-0.2% | $1.42M-63.9% | $3.94M+120% | $1.79M+216% | ||
| -$1.94M+69.6% | -$6.38M-140% | -$2.66M-192% | $2.88M+447% | $526K-58.7% | ||
| $181K-98.5% | $11.74M+3,064% | -$396K-200% | $395K-69.6% | $1.3M+174% | ||
| -$2.12M+88.3% | -$18.12M-701% | -$2.26M-191% | $2.48M+421% | -$772K-196% | ||
| -2.8%+21.3pp | -24.1%-21.6pp | -2.5%-4.9pp | 2.3%+3.0pp | -0.7%-1.3pp | ||
| -$0.19+88.5% | -$1.65-686% | -$0.21-195% | $0.22+414% | -$0.07-200% | ||
| -$0.19+88.5% | -$1.65-686% | -$0.21-191% | $0.23+429% | -$0.07-200% | ||
| 11M+0.2% | 11M-0.1% | 11M-0.6% | 11.1M+1.0% | 10.9M-0.1% | ||
| 11M+0.2% | 11M-0.1% | 11M0.0% | 11M+0.4% | 10.9M+0.2% | ||
| -$66K-2,300% | $3K-78.6% | $14K+102% | -$620K-200% | $620K+275% | ||
| $0-100% | $12.11M+1,969% | -$648K-3,140% | -$20K-200% | $20K+100% | ||
| -$63K+83.1% | -$372K+38.6% | -$606K-7,475% | -$8K+97.9% | -$387K-918% | ||
| $241K— | —— | —— | —— | $2.91M— | ||
| -$1.45M+66.3% | -$4.3M-734% | -$516K+96.1% | -$13.1M-118% | -$6M+46.5% | ||
| -$200K+75.5% | -$816K— | $0+100% | -$7.14M-726% | $1.14M-88.3% | ||
| $1.18M+139% | -$2.98M+57.4% | -$7M+23.6% | -$9.16M-200% | -$3.06M— | ||
| -$262K-114% | $1.89M— | $0-100% | $267K+551% | $41K+109% | ||
| -$649K— | —— | -$2.23M-336% | -$512K-601% | -$73K— | ||
| -$901K— | —— | —— | -$2K+99.6% | -$563K-56,200% | ||
| -$17.13M-246% | -$4.95M+65.3% | -$14.28M-207% | $13.36M+750% | -$2.05M+89.4% | ||
| $260K— | —— | $12.11M— | —— | $3.41M— | ||
| -$25K-2,600% | $1K+150% | -$2K-100% | $2.57M+428% | $487K+226% | ||
| $87K— | —— | —— | $1K-99.5% | $194K— | ||
| $49.32M+49.9% | $32.91M+61.1% | $20.43M+27.1% | $16.07M+7.2% | $14.99M-32.6% | ||
| $1.1M-18.9% | $1.35M-0.9% | $1.36M-1.1% | $1.38M-9.5% | $1.52M-33.4% | ||
| $29.65M+1.1% | $29.31M+290% | $7.52M-75.6% | $30.81M+113% | $14.46M+184% | ||
| $76.04M+1.3% | $75.1M-16.0% | $89.41M-15.3% | $105.56M-8.8% | $115.73M-2.8% | ||
| $1.9M-12.7% | $2.17M+139% | $910K-65.4% | $2.63M+36.1% | $1.93M-9.5% | ||
| -$3.3M+57.8% | -$7.8M-91.2% | -$4.08M-283% | -$1.07M+15.5% | -$1.26M-278% | ||
| $188K+104% | -$4.34M-590% | -$629K-121% | $2.98M+47.6% | $2.02M-48.2% | ||
| $188K+104% | -$4.34M-590% | -$629K-121% | $2.98M+47.6% | $2.02M-48.2% | ||
| 0.2%+6.0pp | -5.8%-5.1pp | -0.7%-3.5pp | 2.8%+1.1pp | 1.7%-1.5pp | ||
| -$3.3M+57.8% | -$7.8M-91.2% | -$4.08M-283% | -$1.07M+15.5% | -$1.26M-278% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medifast's revenue?
- Medifast (MED) generated $346.1M in revenue over the trailing twelve months, down 36.3% year over year.
- Is Medifast profitable?
- Medifast is not currently profitable: it reported a net loss of $20.0M over the trailing twelve months, a -5.8% net margin.
- What are Medifast's profit margins?
- Gross margin is 70.1% and operating margin is -4.7%, with a -5.8% net margin.
- What is Medifast's earnings per share?
- Medifast's diluted EPS over the trailing twelve months is $-1.83.
- Where does Medifast's income statement data come from?
- Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
